Perrigo to Buy Elan for $8.6 Billion

DUBLIN -- U.S. drugmaker Perrigo (PRGO) has agreed to buy Ireland's Elan (ELN) for $8.6 billion in a deal designed to expand overseas and reduce its tax bill.

Michigan-based Perrigo said it will pay Elan investors $6.25 per share in cash and $10.25 in Perrigo stock. The deal represents an 11% premium over Elan's closing price Friday.

Earlier this month, Elan said it was open to offers after spending months fighting a hostile, lower-priced takeover bid by Royal Pharma.

Perrigo said Monday it will become an Irish-based company and said it could cut its tax liabilities nearly in half, saving more than $150 million annually.

About 700 U.S. companies based in Ireland pay a 12.5% rate of tax on profits, versus the U.S. rate of 35%.

Elan confirmed the deal.

Copyright 2011 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

More from Stocks

Quick Read: 3 Things for Investors to Know Before Wednesday's Trading Session

Quick Read: 3 Things for Investors to Know Before Wednesday's Trading Session

Replay: Jim Cramer on the Markets, Oil, General Electric, Zillow and Micron

Replay: Jim Cramer on the Markets, Oil, General Electric, Zillow and Micron

Pegasystems Founder Explains Why He Has One of the Hottest Tech Stocks Around

Pegasystems Founder Explains Why He Has One of the Hottest Tech Stocks Around

Micron Shares Soar; Chipmaker Is 'Managing for Profitability' Now, Says Analyst

Micron Shares Soar; Chipmaker Is 'Managing for Profitability' Now, Says Analyst

Dow Slips 178 Points; S&P 500 and Nasdaq Also Decline

Dow Slips 178 Points; S&P 500 and Nasdaq Also Decline